SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-104272
Filing Date
2023-09-27
Accepted
2023-09-27 16:03:30
Documents
12
Period of Report
2023-09-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327078d1_8k.htm   iXBRL 8-K 24511
  Complete submission text file 0001104659-23-104272.txt   197493

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230927.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230927_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230927_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2327078d1_8k_htm.xml XML 3300
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 231284763
SIC: 2834 Pharmaceutical Preparations